159 related articles for article (PubMed ID: 6210206)
1. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
[TBL] [Abstract][Full Text] [Related]
2. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
Linch DC; Nadler LM; Luther EA; Lipton JM
J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
Lu L; Pelus LM; Broxmeyer HE
Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
Ottmann OG; Nocka KH; Moore MA; Pelus LM
Leukemia; 1988 Oct; 2(10):677-86. PubMed ID: 3172844
[TBL] [Abstract][Full Text] [Related]
5. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
Falkenburg JH; Fibbe WE; Veenhof WF; Koning F; van Eeden G; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
Greenberg P; Grossman M; Charron D; Levy R
Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells.
Falkenburg JH; Jansen J; van der Vaart-Duinkerken N; Veenhof WF; Blotkamp J; Goselink HM; Parlevliet J; van Rood JJ
Blood; 1984 May; 63(5):1125-32. PubMed ID: 6201213
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells.
Fitchen JH; Ferrone S; Quaranta V; Molinaro GA; Cline MJ
J Immunol; 1980 Nov; 125(5):2004-8. PubMed ID: 6159398
[TBL] [Abstract][Full Text] [Related]
9. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
[TBL] [Abstract][Full Text] [Related]
10. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells.
Falkenburg JH; Koning F; Duinkerken N; Fibbe WE; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):90-6. PubMed ID: 3002833
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
16. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
[TBL] [Abstract][Full Text] [Related]
17. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
Dowding CR; Gordon MY; Goldman JM
Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.
Goldman JM; Hibbin J; Kearney L; Orchard K; Th'ng KH
Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244
[TBL] [Abstract][Full Text] [Related]
19. Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens.
Falkenburg JH; Fibbe WE; Goselink HM; Van Rood JJ; Jansen J
J Exp Med; 1985 Oct; 162(4):1359-69. PubMed ID: 3862746
[TBL] [Abstract][Full Text] [Related]
20. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
